Publication date: November 2026 Source: ESMO Open, Volume 11, Issue 11 Author(s): H. Timmer, A.H. Huisman, H. Gelderblom, S. Barjesteh van Waalwijk van Doorn-Khosrovani
Mapping off-label use and reimbursement pathways for oncology drugs in The Netherlands: a cross-sectional observational study. // ESMO Open. – URL: https://www.sciencedirect.com/science/article/pii/S2059702926025548?dgcid=rss_sd_all
Mapping off-label use and reimbursement pathways for oncology drugs in The Netherlands: a cross-sectional observational study. ESMO Open. https://www.sciencedirect.com/science/article/pii/S2059702926025548?dgcid=rss_sd_all
“Mapping off-label use and reimbursement pathways for oncology drugs in The Netherlands: a cross-sectional observational study.” ESMO Open.
@article{article93748,
title = {Mapping off-label use and reimbursement pathways for oncology drugs in The Netherlands: a cross-sectional observational study},
journal = {ESMO Open},
url = {https://www.sciencedirect.com/science/article/pii/S2059702926025548?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment